GPR91 senses extracellular succinate released from inflammatory macrophages and exacerbates rheumatoid arthritis

Author:

Littlewood-Evans Amanda1ORCID,Sarret Sophie1ORCID,Apfel Verena1ORCID,Loesle Perrine1ORCID,Dawson Janet1ORCID,Zhang Juan2,Muller Alban2ORCID,Tigani Bruno3ORCID,Kneuer Rainer3,Patel Saijel1ORCID,Valeaux Stephanie1ORCID,Gommermann Nina4ORCID,Rubic-Schneider Tina5ORCID,Junt Tobias1ORCID,Carballido José M.1ORCID

Affiliation:

1. Department of Autoimmunity Transplantation and Inflammation, Novartis Institutes for BioMedical Research, 4002 Basel, Switzerland

2. Department of Analytical Science and Imaging, Novartis Institutes for BioMedical Research, 4002 Basel, Switzerland

3. Global Imaging Group, Novartis Institutes for BioMedical Research, 4002 Basel, Switzerland

4. Global Discovery Chemistry, Novartis Institutes for BioMedical Research, 4002 Basel, Switzerland

5. Preclinical Safety Division, Novartis Institutes for BioMedical Research, 4002 Basel, Switzerland

Abstract

When SUCNR1/GPR91-expressing macrophages are activated by inflammatory signals, they change their metabolism and accumulate succinate. In this study, we show that during this activation, macrophages release succinate into the extracellular milieu. They simultaneously up-regulate GPR91, which functions as an autocrine and paracrine sensor for extracellular succinate to enhance IL-1β production. GPR91-deficient mice lack this metabolic sensor and show reduced macrophage activation and production of IL-1β during antigen-induced arthritis. Succinate is abundant in synovial fluids from rheumatoid arthritis (RA) patients, and these fluids elicit IL-1β release from macrophages in a GPR91-dependent manner. Together, we reveal a GPR91/succinate-dependent feed-forward loop of macrophage activation and propose GPR91 antagonists as novel therapeutic principles to treat RA.

Funder

Novartis Pharma AG

Publisher

Rockefeller University Press

Subject

Immunology,Immunology and Allergy

Cited by 320 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3